Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier, Walter Prof. Dr. (1) Hinz, Michael Dr. (1) Janz, Martin Dr. (9) Kammertöns, Thomas Dr. (1) Kieback, Elisa Dr. (1) Kobelt, Dennis Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (9) Röefzaad, Claudia (1) Scheidereit, Claus Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (89) Smith, Janice (2) Stein, Ulrike Prof. Dr. (20) Uckert, Wolfgang Prof. Dr. (6) Walther, Wolfgang Prof. Dr. (17) Willimsky, Gerald Dr. (2) Wollert-Wulf, Brigitte (2) (-) Blankenstein, Thomas Prof. Dr. (21) (-) Daniel, Peter Prof. Dr. (3) (-) Biologie maligner Lymphome (1) (-) Molekulare Immunologie und Gentherapie (21) Proteom Dynamik (6) Systembiologie von Gen-regulatorischen Elementen (1) (-) Translationale Onkologie solider Tumore (3) 1992 (4) 1993 (7) 1994 (5) 1995 (8) (-) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) (-) 2003 (10) 2004 (8) 2005 (10) (-) 2006 (3) 2007 (5) (-) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (3) 2015 (4) 2016 (4) 2017 (7) 2018 (4) 2019 (7) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 24 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie Translationale Onkologie solider Tumore1996200320062008 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1996 / Rev Physiol Biochem Pharmacol Genetic approaches to cancer immunotherapy T. Blankenstein S. Cayeux Z. Qin 01. Januar 1996 / Eur J Immunol Attenuation of collagen induced-arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 N. Bessis M.C. Boissie P. Ferrara T. Blankenstein D. Fradelizi C. Fournier 01. Januar 1996 / Nature Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S. Brocke K. Gijbels M. Allegretta I. Ferber C. Piercy T. Blankenstein R. Martin U. Utz N. Karin D. Mitchell T. Veromaa A. Waisman A. Gaur P. Conlon N. Ling P.J. Fairchild D.C. Wraith A. Ogarra C.G. Fathman L. Steinman 01. Januar 1996 / Gene Ther Cancer vaccines in gene therapy T. Blankenstein Z. Qin 01. Januar 1996 / Hum Gene Ther Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant S. Cayeux C. Beck B. Doerken T. Blankenstein 01. Januar 1996 / Curr Top Microbiol Immunol The influence of local cytokines on tumor metastasis: using cytokine gene transfected tumor cells as experimental models Z. Qin T. Blankenstein 15. September 2003 / J Clin Oncol Dynamic expression profile of p21 WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy B. Rau I. Sturm H. Lage S. Berger U. Schneider S. Haupfmann P. Wust H. Riess P.M. Schlag B. Doerken P.T. Daniel 17. November 2003 / J Exp Med Tumor rejection by modulation of tumor stromal fibroblasts T. Schueler S. Koernig T. Blankenstein 01. Dezember 2003 / J Mol Med Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes M.D. Muehlebach I. Schmitt S. Steidl J. Stitz M. Schweizer T. Blankenstein K. Cichutek W. Uckert 01. Januar 2003 / Adv Cancer Res Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance T. Blankenstein Z. Qin Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. Januar 1996 / Rev Physiol Biochem Pharmacol Genetic approaches to cancer immunotherapy T. Blankenstein S. Cayeux Z. Qin
01. Januar 1996 / Eur J Immunol Attenuation of collagen induced-arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 N. Bessis M.C. Boissie P. Ferrara T. Blankenstein D. Fradelizi C. Fournier
01. Januar 1996 / Nature Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S. Brocke K. Gijbels M. Allegretta I. Ferber C. Piercy T. Blankenstein R. Martin U. Utz N. Karin D. Mitchell T. Veromaa A. Waisman A. Gaur P. Conlon N. Ling P.J. Fairchild D.C. Wraith A. Ogarra C.G. Fathman L. Steinman
01. Januar 1996 / Hum Gene Ther Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant S. Cayeux C. Beck B. Doerken T. Blankenstein
01. Januar 1996 / Curr Top Microbiol Immunol The influence of local cytokines on tumor metastasis: using cytokine gene transfected tumor cells as experimental models Z. Qin T. Blankenstein
15. September 2003 / J Clin Oncol Dynamic expression profile of p21 WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy B. Rau I. Sturm H. Lage S. Berger U. Schneider S. Haupfmann P. Wust H. Riess P.M. Schlag B. Doerken P.T. Daniel
17. November 2003 / J Exp Med Tumor rejection by modulation of tumor stromal fibroblasts T. Schueler S. Koernig T. Blankenstein
01. Dezember 2003 / J Mol Med Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes M.D. Muehlebach I. Schmitt S. Steidl J. Stitz M. Schweizer T. Blankenstein K. Cichutek W. Uckert
01. Januar 2003 / Adv Cancer Res Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance T. Blankenstein Z. Qin